Immatics (IMTX) has had the highest return between September 29, 2015 and September 29, 2025 by a US stock in the Biotechnology Industry, returning 153,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immatics (IMTX) | 9/29/2015 - 9/29/2025 | 153,900% |
MDxHealth SA ADR (MDXH) | 9/29/2015 - 9/29/2025 | 107,574.42% |
Azitra (AZTR) | 9/29/2015 - 9/29/2025 | 12,400% |
Regencell Bioscience (RGC) | 9/29/2015 - 9/29/2025 | 4,681.51% |
argenx NV ADR (ARGX) | 9/29/2015 - 9/29/2025 | 3,875.53% |
COSCIENS Biopharma (CSCI) | 9/29/2015 - 9/29/2025 | 2,542.5% |
NewAmsterdam Pharma Company NV Warrant (NAMSW) | 9/29/2015 - 9/29/2025 | 1,719% |
Krystal Biotech (KRYS) | 9/29/2015 - 9/29/2025 | 1,498.29% |
Natera (NTRA) | 9/29/2015 - 9/29/2025 | 1,234.73% |
AquaBounty Technologies (AQB) | 9/29/2015 - 9/29/2025 | 1,177.78% |
Vericel Corp Ord (VCEL) | 9/29/2015 - 9/29/2025 | 1,154.36% |
Ascendis Pharma A-S (ASND) | 9/29/2015 - 9/29/2025 | 1,070.67% |
BeiGene (ONC) | 9/29/2015 - 9/29/2025 | 1,025.51% |
Cytokinetics (CYTK) | 9/29/2015 - 9/29/2025 | 673.01% |
Insmed (INSM) | 9/29/2015 - 9/29/2025 | 654.16% |
Abivax SA American Depositary Shares (ABVX) | 9/29/2015 - 9/29/2025 | 614.14% |
Madrigal Pharmaceuticals (MDGL) | 9/29/2015 - 9/29/2025 | 612.99% |
Merus (MRUS) | 9/29/2015 - 9/29/2025 | 606.56% |
Exelixis (EXEL) | 9/29/2015 - 9/29/2025 | 577.78% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 9/29/2015 - 9/29/2025 | 564.26% |
AbbVie (ABBV) | 9/29/2015 - 9/29/2025 | 531% |
MoonLake Immunotherapeutics (MLTX) | 9/29/2015 - 9/29/2025 | 510.14% |
Veracyte (VCYT) | 9/29/2015 - 9/29/2025 | 508% |
BioNTech SE (BNTX) | 9/29/2015 - 9/29/2025 | 494.42% |
Catalyst Pharmaceuticals (CPRX) | 9/29/2015 - 9/29/2025 | 475.81% |
